Cordyceps Sunshine Biotech Holdings Co., Ltd. (ticker: RAJAF) is an OTC-listed us cannabis company. DredgeCap's structured extraction of RAJAF's SEC filings surfaces 5 active risk signals, including 4 late-filing signals, and 1 auditor-change signal. RAJAF reported $1.25M in revenue and -$226K for the period ending 2024-12-31, with operating cash flow of $312K. Cash and equivalents stood at $37K (up 61.4% year-over-year). Total assets of $4.62M are exceeded by total liabilities of $5.00M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
RAJAF Legal Proceedings
DredgeCap has not located any disclosed legal proceedings for Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) in the SEC filings currently cached or in the federal-court records searched. 0 periodic filings reviewed, 0 with specific disclosure content. The absence of records here does not certify that the company is free of litigation — coverage reflects only what DredgeCap has cached.